Nonsense-Mediated mRNA Decay and Ubiquitin-Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice

被引:133
作者
Vignier, Nicolas [2 ,3 ]
Schlossarek, Saskia [1 ]
Fraysse, Bodvael [2 ,3 ]
Mearini, Giulia [1 ]
Kraemer, Elisabeth [1 ]
Pointu, Herve
Mougenot, Nathalie [3 ]
Guiard, Josiane
Reimer, Rudolph
Hohenberg, Heinrich [6 ]
Schwartz, Ketty [2 ]
Vernet, Muriel [4 ,5 ]
Eschenhagen, Thomas [1 ]
Carrier, Lucie [1 ,2 ,3 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, Cardiovasc Res Ctr, D-20246 Hamburg, Germany
[2] INSERM, U582, U974, Paris, France
[3] Univ Paris 06, CNRS, UMR S974, UMR 7215,IFR14,Inst Myol, Paris, France
[4] Commissariat Energie Atom Grenoble, iRTSV, Grenoble, France
[5] Commissariat Energie Atom Fontenay, iRCM, Fontenay Aux Roses, France
[6] Univ Hamburg, Heinrich Pette Inst, Hamburg, Germany
关键词
cardiomyopathy; hypertrophic cardiomyopathy; mRNA stability; transgenic mice; ubiquitin; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SPLICE DONOR SITE; DILATED CARDIOMYOPATHY; SEPTAL HYPERTROPHY; IN-VIVO; MUTATIONS; GENE; IMPAIRMENT; ORGANIZATION; TRANSCRIPTS;
D O I
10.1161/CIRCRESAHA.109.201251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Mutations in the MYBPC3 gene encoding cardiac myosin-binding protein (cMyBP)-C are frequent causes of hypertrophic cardiomyopathy, but the mechanisms leading from mutations to disease remain elusive. Objective: The goal of the present study was therefore to gain insights into the mechanisms controlling the expression of MYBPC3 mutations. Methods and Results: We developed a cMyBP-C knock-in mouse carrying a point mutation. The level of total cMyBP-C mRNAs was 50% and 80% lower in heterozygotes and homozygotes, respectively. Surprisingly, the single G>A transition on the last nucleotide of exon 6 resulted in 3 different mutant mRNAs: missense (exchange of G for A), nonsense (exon skipping, frameshift, and premature stop codon) and deletion/insertion (as nonsense but with additional partial retention of downstream intron, restoring of the reading frame, and almost full-length protein). Inhibition of nonsense-mediated mRNA decay in cultured cardiac myocytes or in vivo with emetine or cycloheximide increased the level of nonsense mRNAs severalfold but not of the other mRNAs. By using sequential protein fractionation and a new antibody directed against novel amino acids produced by the frameshift, we showed that inhibition of the proteasome with epoxomicin via osmotic minipumps increased the level of (near) full-length mutants but not of truncated proteins. Homozygotes exhibited myocyte and left ventricular hypertrophy, reduced fractional shortening, and interstitial fibrosis; heterozygotes had no major phenotype. Conclusions: These data reveal (1) an unanticipated complexity of the expression of a single point mutation in the whole animal and (2) the involvement of both nonsense-mediated mRNA decay and the ubiquitin-proteasome system in lowering the level of mutant proteins. (Circ Res. 2009; 105: 239-248.)
引用
收藏
页码:239 / U89
页数:23
相关论文
共 44 条
  • [31] Cardiac myosin-binding protein c is required for complete relaxation in intact myocytes
    Pohlmann, Lutz
    Kroeger, Irena
    Vignier, Nicolas
    Schlossarek, Saskia
    Kraemer, Elisabeth
    Coirault, Catherine
    Sultan, Karim R.
    El-Armouche, Ali
    Winegrad, Saul
    Eschenhagen, Thomas
    Carrier, Lucie
    [J]. CIRCULATION RESEARCH, 2007, 101 (09) : 928 - 938
  • [32] USE OF LEAD CITRATE AT HIGH PH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY
    REYNOLDS, ES
    [J]. JOURNAL OF CELL BIOLOGY, 1963, 17 (01) : 208 - &
  • [33] Hypertrophic cardiomyopathy - Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy
    Richard, P
    Charron, P
    Carrier, L
    Ledeuil, C
    Cheav, T
    Pichereau, C
    Benaiche, A
    Isnard, R
    Dubourg, O
    Burban, M
    Gueffet, JP
    Millaire, A
    Desnos, M
    Schwartz, K
    Hainque, B
    Komajda, M
    [J]. CIRCULATION, 2003, 107 (17) : 2227 - 2232
  • [34] The genetic bases of cardiomyopathies
    Richard, Pascale
    Villard, Eric
    Charron, Philippe
    Isnard, Richard
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (09) : A79 - A89
  • [35] Report of the 1995 World Health Organization International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
    Richardson, P
    McKenna, W
    Bristow, M
    Maisch, B
    Mautner, B
    OConnell, J
    Olsen, E
    Thiene, G
    Goodwin, J
    Gyarfas, I
    Martin, I
    Nordet, P
    [J]. CIRCULATION, 1996, 93 (05) : 841 - 842
  • [36] Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy - Characterization of cardiac transcript and protein
    Rottbauer, W
    Gautel, M
    Zehelein, J
    Labeit, S
    Franz, WM
    Fischer, C
    Vollrath, B
    Mall, G
    Dietz, R
    Kubler, W
    Katus, HA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) : 475 - 482
  • [37] GENETICS AND BIOCHEMISTRY OF CRYPTOPLEURINE RESISTANCE IN YEAST SACCHAROMYCES-CEREVISIAE
    SANCHEZ, L
    VASQUEZ, D
    JIMENEZ, A
    [J]. MOLECULAR & GENERAL GENETICS, 1977, 156 (03): : 319 - 326
  • [38] Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants
    Sarikas, A
    Carrier, L
    Schenke, C
    Doll, D
    Flavigny, J
    Lindenberg, KS
    Eschenhagen, T
    Zolk, O
    [J]. CARDIOVASCULAR RESEARCH, 2005, 66 (01) : 33 - 44
  • [39] Schuermann F, 2008, CIRCULATION, V118, pS521
  • [40] Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium
    Stelzer, Julian E.
    Dunning, Sandy B.
    Moss, Richard L.
    [J]. CIRCULATION RESEARCH, 2006, 98 (09) : 1212 - 1218